𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Incidental Hepatocellular Carcinoma in Liver Transplant Recipients is Associated With Fatty Liver Disease and Conveys a Low Risk of Recurrent Malignancy After Transplant

✍ Scribed by M.H. Levine; K. Enestvedt; P. Porrett; R. Cui; M. Hoteit; Y. Mu; E. Siegelman; S. Sonnad; P.L. Abt; A. Shaked; K. Olthoff

Book ID
116708043
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
60 KB
Volume
172
Category
Article
ISSN
0022-4804

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Recurrence of hepatitis B is associated
Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation
✍ Nam-Joon Yi; Kyung-Suk Suh; Jai Young Cho; Choon Hyuck Kwon; Kwang-Woong Lee; Ja πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 1 views

The incidence of hepatitis B (HB) recurrence after a liver transplantation has been reduced by prophylaxis with hepatitis B immunoglobulin (HBIG) and lamivudine. However, the long-term incidence of recurrence is Ο½10%, and the factors associated with HB recurrence are unclear. This study analyzed the

MDR1 gene polymorphisms and risk of recu
MDR1 gene polymorphisms and risk of recurrence in patients With hepatocellular carcinoma after liver transplantation
✍ Liming Wu; Xiaobo Xu; Juwei Shen; Haiyang Xie; Songfeng Yu; Tingbo Liang; Weilin πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

## Abstract ## Background and Objectives Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) remains a major cause of post‐LT death. However, currently there is still lacking the markers to reliably predict recurrence. This study was undertaken to evaluate the association